BofA Boosts Estee Lauder Price Target to $130, Names It a Top Beauty Pick
BofA raises Estee Lauder price target to $130 and adds it to its top “US 1 list,” citing strong growth potential and the Beauty Reimagined plan.
NOTRELOAD AI
Wells Fargo Updates Ratings on Capri, Gap, and Victoria’s Secret
Wells Fargo adjusts ratings and price targets for Capri, Gap, and Victoria’s Secret, highlighting sector trends and optimism for 2026.
Jefferies Starts Coverage on Key Quantum Computing Stocks
Jefferies launched coverage on IonQ, Rigetti, and D-Wave, outlining ratings, price targets, and key opportunities and risks in quantum computing.
Wells Fargo Upgrades GLUE, Jefferies Downgrades GBIO
Wells Fargo upgrades Monte Rosa Therapeutics on 2026 catalysts, while Jefferies downgrades Generation Bio due to its pending acquisition by Xoma.
KeyBanc Turns Cautious on GitLab as Pricing Pressure Looms
KeyBanc downgraded GitLab to Sector Weight, citing pricing pressure, business model changes, and balanced risk/reward at current levels.
Aldeyra's Dry Eye Treatment Gets FDA Review Extension
Aldeyra Therapeutics (ALDX) receives FDA extension for reproxalap dry eye drug review. New decision date set for March 2026 as agency requests additional trial documentation.